APA (7th ed.) Citation

Dreikhausen, L., Kusnik, A., Schulte, N., Eckardt, M., Teufel, A., Gaiser, T., . . . Zhan, T. (2021). Durable response with lenvatinib and pembrolizumab combination therapy in a patient with pre-treated metastatic cholangiocarcinoma. Journal of Gastrointestinal & Liver Diseases, 30(3), 409. https://doi.org/10.15403/jgld-3730

Chicago Style (17th ed.) Citation

Dreikhausen, Lena, Alexander Kusnik, Nadine Schulte, Maximilian Eckardt, Andreas Teufel, Timo Gaiser, Matthias Ebert, and Tianzuo Zhan. "Durable Response with Lenvatinib and Pembrolizumab Combination Therapy in a Patient with Pre-treated Metastatic Cholangiocarcinoma." Journal of Gastrointestinal & Liver Diseases 30, no. 3 (2021): 409. https://doi.org/10.15403/jgld-3730.

MLA (9th ed.) Citation

Dreikhausen, Lena, et al. "Durable Response with Lenvatinib and Pembrolizumab Combination Therapy in a Patient with Pre-treated Metastatic Cholangiocarcinoma." Journal of Gastrointestinal & Liver Diseases, vol. 30, no. 3, 2021, p. 409, https://doi.org/10.15403/jgld-3730.